SLC22A4 and cancer: Although low expression of OCTN1 is reportedly a strong predictor of poor event-free survival [57], the contribution of an STDME diet to cancer progression and whether MDSCs preferentially incorporate selenoneine compared with cancer cells are both still unknown.